Literature DB >> 15198423

Infliximab dose and charge escalation patterns in managed care.

Dorothy George1, Pam Kadlubek, Deepika Batra, George Goldberg.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15198423

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN： 1096-5645


× No keyword cloud information.
  3 in total

Review 1.  Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.

Authors:  Paul Anderson; James Louie; Anna Lau; Michael Broder
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

Review 2.  Dose modifications of anti-TNF drugs in rheumatoid arthritis patients under real-world settings: a systematic review.

Authors:  Rafael Ferriols-Lisart; Francisco Ferriols-Lisart
Journal:  Rheumatol Int       Date:  2015-02-01       Impact factor: 2.631

3.  [Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologics Register RABBIT].

Authors:  A Zink; J Listing; A Strangfeld; E Gromnica-Ihle; W Demary; M Schneider
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.